INSIGHTS ON DRUG DEVELOPMENT

  • De-Risking Drug Development: Informatics-Supported Solid Form Selection
    5/6/2026

    Learn how combining polymorph screening with structural informatics improves solid‑form selection, lowers development risk, and boosts confidence in long‑term stability and manufacturability.

  • Optimize Your RNA-LNP Delivery With Ionizable Lipids
    4/3/2025

    Ionizable lipids play a crucial role in optimizing LNP delivery. Discover how lipid nanoparticles revolutionize intracellular drug delivery to enhance RNA vaccines, cell therapies, protein replacement, and gene editing.

  • Patient-Centric Formulations In Pediatric Adherence
    11/13/2025

    Improving pediatric adherence requires age-appropriate formulations, taste-masking, and swallowability strategies. Regulatory, clinical, and technological insights help overcome barriers and support safer, more effective therapies for children across developmental stages.

  • From 51% Yield To 87% With Targeted Impurity Removal
    5/7/2026

    Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.

  • In Vivo Testing Of Nasal Dosage Forms
    5/7/2025

    Innovative nasal drug delivery strategies can unlock faster, patient-friendly therapeutic solutions by combining smart formulation, advanced testing platforms, and rigorous preclinical evaluation.

DRUG DEVELOPMENT SOLUTIONS

  • The BioAccord™ LC-MS System with dedicated workflows for the Sartorius Ambr® 15 and small bioreactors enables process engineers to directly measure Product Quality Attributes (PQAs) and cell culture media.

  • Rapid, high-throughput IgG quantification assay. Available in 96 & 384-well microplate options.

  • Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.

  • Flexible, reliable control and bioreactor systems for laboratory applications

    Thermo Scientific™ HyPerforma™ bioprocess control systems are designed to optimize your process from the laboratory bench to full cGMP manufacturing. Our innovative control platform combines a flexible operating system with scalable, modular hardware, novel single-use sensors, and state-of-the-art bioreactors for strategic and streamlined bioprocess control.

    HyPerforma benchtop solutions offer robust management of both cell culture and fermentation processes. The open architecture provides process flexibility, and dedicated hardware control allows for expansion. Thermo Scientific™ TruBio™ software is designed to support easy process control and scaling.

  • Backed by trusted data and deep scientific expertise, learn how our adaptive approach ensures seamless progression from preclinical development to commercial manufacturing.